These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22959854)

  • 1. Reply to John E. Madias, MD, FACC, FAHA: MTWA and/or LVEF in ischemic cardiomyopathy.
    Chen Z; Zou J
    Int J Cardiol; 2013 May; 165(2):368. PubMed ID: 22959854
    [No Abstract]   [Full Text] [Related]  

  • 2. Microvolt T-wave alternans in ischemic cardiomyopathy.
    Madias JE
    Int J Cardiol; 2013 Jan; 162(2):135-6. PubMed ID: 22795709
    [No Abstract]   [Full Text] [Related]  

  • 3. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic refinement of risk stratification: can we achieve the goal?
    Israel CW; Hohnloser SH
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):177-8. PubMed ID: 15028047
    [No Abstract]   [Full Text] [Related]  

  • 6. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographically concealed variation in left ventricular capture: a case with implications for resynchronization therapy in ischemic cardiomyopathy.
    Grimley SR; Suffoletto MS; Gorcsan J; Schwartzman D
    Heart Rhythm; 2006 Jun; 3(6):739-42. PubMed ID: 16731481
    [No Abstract]   [Full Text] [Related]  

  • 8. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
    Rashba EJ; Osman AF; Macmurdy K; Kirk MM; Sarang SE; Peters RW; Shorofsky SR; Gold MR
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):170-6. PubMed ID: 15028046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
    Marrouche NF; Verma A; Wazni O; Schweikert R; Martin DO; Saliba W; Kilicaslan F; Cummings J; Burkhardt JD; Bhargava M; Bash D; Brachmann J; Guenther J; Hao S; Beheiry S; Rossillo A; Raviele A; Themistoclakis S; Natale A
    J Am Coll Cardiol; 2004 May; 43(9):1715-20. PubMed ID: 15120835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial viability in ischemic cardiomyopathy.
    Bax JJ
    Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathy.
    Rizzello V; Poldermans D; Biagini E; Schinkel AF; Elhendy A; Leone AM; Crea F; Maat A; Roelandt JR; Bax JJ
    Am J Cardiol; 2005 Aug; 96(3):386-9. PubMed ID: 16054464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two different cycle lengths during left ventricular pacing: what is the mechanism?
    Chan JY; Fung JW; Yu CM
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):685-6. PubMed ID: 16836724
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins reduce appropriate implantable cardioverter-defibrillator shocks in ischemic cardiomyopathy with no benefit in nonischemic cardiomyopathy.
    Contractor T; Beri A; Gardiner J; Ardhanari S; Thakur R
    Am J Ther; 2012 Nov; 19(6):413-8. PubMed ID: 22185754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular reconstruction: the aim and the reality after twenty years.
    Dor V
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):17-20. PubMed ID: 15224016
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year.
    Chan PS; Kereiakes DJ; Bartone C; Chow T
    Am J Cardiol; 2008 Aug; 102(3):280-4. PubMed ID: 18638586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
    Schenk S; McCarthy PM; Starling RC; Hoercher KJ; Hail MD; Ootaki Y; Francis GS; Doi K; Young JB; Fukamachi K
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):38-43. PubMed ID: 15224019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is the surgical ventricular restoration operation effective for ischemic cardiomyopathy? Geometric analysis with magnetic resonance imaging of changes in regional ventricular function after surgical ventricular restoration.
    Yu HY; Chen YS; Tseng WY; Chi NS; Wang CH; Wang SS; Lin FY
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):887-94. PubMed ID: 19327513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.